Navigation Links
Beckman Coulter's 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
Date:2/8/2008

contributed 0.8% to this growth. Compared to prior year, Clinical Diagnostics revenue grew 11.9%, while sales to life sciences markets declined 2%.

Consumables revenue grew 10.6%, or 8.3% in constant currency. The Lumigen contribution to consumables sales growth was 1.4%. Access Immunoassay consumables grew 21.5% accelerating from 2006. Full year 2007 recurring revenue was up 11.8% to $2,162.8 million, or 78.3% of total revenue.

Gross profit margin declined 40 basis points from prior year to 46.9%, driven primarily by a temporary increase in distribution costs largely resulting from the 2007 implementation of the U.S. ERP program and printed circuit board supply issues.

Operating income for the year was $272.4 million. Adjusted operating income was $327.1 million, or 11.8% of revenue.

Non-operating income was $20.3 million, including a gain of $26.2 million from the company's Miami land sale and the Biosite transaction break up fee of $40.6 million. These gains were partially offset by a $9 million contribution to establish the Beckman Coulter Foundation. Non-operating expense excluding these items was approximately $37 million, compared to $40 million in 2006.

The tax rate for the year was 28.4%, up from 26.6% in the prior year period primarily due to a shift in geographic profit mix in 2007 and the phase out of certain manufacturing tax credits.

Earnings per fully diluted share were $3.30, up 13% over prior year. Adjusted earnings per fully diluted share were $3.25, exceeding the company's outlook range of $3.15 to $3.22. (See "Non-GAAP Financial Measures.")

Garrett continued, "For the full year 2007, free cash flow improved by $116.2 million to $122.7 million. EBITDA increased 24% over 2006. These improvements were driven in large part by the growing benefits of moving to an operating-type lease business model. The positive trends in free cash flow and EBITDA will continue going forward, as we close the gap betwee
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine news :

1. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
2. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
3. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
4. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
5. Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference
6. Haemacure Reports Third Quarter 2007 Results
7. Weight Watchers Declares Quarterly Dividend
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. Medical Services International Maintains Pace in Second Quarter
11. Martek Announces Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... (PRWEB) December 26, 2014 ... BambooFlooringChina.com combines beauty, strength and durability. Today, the ... promotion, which is valid until Jan. 30, 2015. ... grain of traditional hardwood. BambooFlooringChina.com is a well-known ... help consumers worldwide to find a reliable bamboo ...
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of wedding dresses and ... of black one-shoulder cocktail dresses . In addition, all ... at discounted prices, up to 70% off. , ... weeks only. You know, we have thousands of frequent callers ... new items can visit our website for more details. The ...
(Date:12/25/2014)... California (PRWEB) December 25, 2014 Helen ... home in Woodland Hills, California after an 8 year ... away on Christmas Eve evening in her home in ... aggressive metastatic breast cancer. , As ... over forty years, she pioneered and championed many of ...
(Date:12/25/2014)... (HealthDay News) -- Overeating is common during the holidays, but ... an expert says. "Don,t arrive at a party hungry. ... know you,ll be attending a party, but deprivation leads to ... at Northern Westchester Hospital in Mount Kisco, N.Y., said in ... during the day and even to have a snack before ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch as part ... mobile applications on the iOS, Android, and Windows markets. Andrew ... the app review and shared with viewers how this is ... old saying goes, “A picture says a thousand words.” It’s ... a single image, because each picture holds a unique and ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... find out why people can,t let go of what is theirs ... thrown a yard sale knows, it can be hard to part ... attempt to grasp this all too human -- and sometimes irrational ... having a tenacious grip on the stuff you own has little ...
... Pharmaceuticals, Inc.,announced today that the U.S. Food and ... Company,s Abbreviated New Drug Application,(ANDA) for Ramipril capsules, ... mg. Commercial,shipments of the product have commenced., ... of King,Pharmaceutical,s Altace(R) capsules, indicated for the treatment ...
... Ind., June 11 Conseco, Inc. (NYSE:,CNO) announced ... vice,president and general counsel of Conseco. Zimpfer, who ... report to CEO Jim Prieur., (Photo: ... in the insurance industry in litigation,legal counsel, compliance ...
... June 11, 2008 A new report entitled Business ... the London School of Hygiene & Tropical Medicine (LSHTM), ... the level of advice given to businesses to prepare ... and disruption to business during a flu pandemic is ...
... It appears that disrupted rest and activity rhythms are ... new University of Minnesota research. , A group of about ... activity biological rhythms via a wrist device called an actigraph. ... rest and activity, as well as the robustness of the ...
... ... and Easy-to-Use, ST. LOUIS, June 11 Millions ... and they want to provide them,with the best care possible for a ... resulted in,dogs and cats living longer than ever before. Many medical advances ...
Cached Medicine News:Health News:Possession Is Nine-Tenths the Perceived Value 2Health News:Possession Is Nine-Tenths the Perceived Value 3Health News:Lupin Launches Ramipril Capsules 2Health News:Lupin Launches Ramipril Capsules 3Health News:European businesses not properly advised on how to prepare for flu pandemic 2Health News:Disturbed rest, activity linked to mortality in older men 2Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 2Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 3Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 4
(Date:12/24/2014)... Dec. 24, 2014  Novastem, a leader in ... patient in its study for ischemic stroke at ... Association, ischemic strokes account for 87 percent of ... patients in the study, entitled "Internal Research Protocol ... Mesenchymal Stem Cells and Intrathecal Administration of Neural ...
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals ... with KX2-361 at Roswell Park Cancer Institute. ... molecule drug that has shown potent inhibitory activity against ... those that are resistant to Temozolomide (T98G), the most ... In a well-established brain tumor mouse model, KX2-361 consistently ...
(Date:12/24/2014)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ), the ... Jennifer Hagerman , Pharm.D., AE-C, senior director of ... the president of the Michigan Pharmacists Association on Jan. ... Feb. 28, 2015, at the MPA Annual Convention and ... in Detroit, Michigan . Hagerman will ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3
... C. Lechleiter, Ph.D., chairman, president and chief executive officer ... ), today urged that biopharmaceuticals be included in transatlantic ... Council on Germany,s conference on "The Transatlantic Partnership in ... German State Secretary in the Federal Finance Ministry Jorg ...
... The U.S. Food and Drug Administration (FDA) has approved ... Vaccine, Adsorbed (Tdap)] for use in adults 65 years ... tetanus, diphtheria and pertussis (whooping cough). This approval makes ... this age group.  With this expanded indication, BOOSTRIX is ...
Cached Medicine Technology:Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions 2GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 2GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 3GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 4
... C. difficile Rapid Toxin A Test gives your ... minutes. When it might be C. difficile, you ... performs only a few tests a day or ... testing, ColorPAC Toxin A C. difficile Rapid Toxin ...
... Clearview C. Diff A ... the direct qualitative detection of ... fecal samples. , ,Clearview C. ... innovative technology to provide fast, ...
... features come back with better resolution, accuracy ... use 25 or 31 rings (same as ... system provides high accuracy & repeatability. The ... shadow & provides extensive corneal coverage. The ...
... the first compact and portable non-contact ... OCULUS Pachycam has automatic correction of ... accordance with Shah or Ehlers to ... OCULUS Pachycam is non-contact pachymetry in ...
Medicine Products: